Evidence map›Paper›PMID 29872510›Full record

ReviewOncotarget2018

B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine.

Paola Rossi, Raffaele Difrancia, Vincenzo Quagliariello, Elena Savino, Paolo Tralongo, Cinzia Lucia Randazzo, Massimiliano Berretta

Open access · diamondAbstract readReview
In one paragraph

Review in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Exploring the Anticancer Potential ofCurrent issues in molecular biology · 2025
    Review
  6. Article
  7. Anti-Cancer Potential of Linear β-(1→6)-D-Glucan fromMolecules (Basel, Switzerland) · 2024
    Article
  8. Review
  9. A Phyto-mycotherapeutic Supplement, NamelyInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Review
  12. Anti-Cancer Potential of Edible/Medicinal Mushrooms in Breast Cancer.International journal of molecular sciences · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Advances in cell death mechanisms involved in viral myocarditis.Frontiers in cardiovascular medicine · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Paola RossiDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy.
Raffaele DifranciaGruppo Oncologico Ricercatori Italiani, GORI onlus, Pordenone, Italy.
Vincenzo QuagliarielloDepartment of Abdominal Oncology, National Cancer Institute, IRCCS - Foundation G. Pascale, Naples, Italy.
Elena SavinoDepartment of Earth and Environmental Science, University of Pavia, Italy.
Paolo TralongoOncology Division Umberto I Hospital, Siracusa, Italy.
Cinzia Lucia RandazzoDepartment of Agricultural, Food and Environment, University of Catania, Italy.
Massimiliano BerrettaDepartment of Medical Oncology, National Cancer Institute, IRCCS, Aviano (PN), Italy.
University of Pavia · ITCentro di Riferimento Oncologico · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITItalian Oncology Group of Clinical Research · ITOspedali Riuniti Umberto I · ITUniversity of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Culinary and medicinal mushrooms are widely used in Asian countries, both as dietary supplements and as nutraceutical foods. They have recently become popular in Europe, as well, for their nutritional and health benefits. In particular, epidemiological studies conducted in Asia suggest that mushroom intake, together with other phytotherapy substances, protects against cancer, specifically gastrointestinal (GI) and breast cancers. Most of the data come from

Indexed as

breast cancerG. frondosaG. lucidumimmunomodulationmicrobiota

Identifiers

PMID29872510
PMCPMC5973856
OpenAlexW2810853676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.